Stocks · News reference
Bank Of America Raises Lakefront Biotherapeutics Stake Above To 10.11%
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America.Pursuant to Belgian transparency legislation1, Lakefront received a transparency notification from
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
What Does the Fed Rate Hike Mean for JPMorgan's Banking Business?
The Federal Reserve's 25 basis point rate hike to 3.75-4.00% is expected to provide modest benefits to JPMorgan's net interest income through higher loan yields, supported by 10% average loan growth and 7% deposit growth in Q2. However, gains may be limited by increased deposit costs, softer loan demand, and rising credit costs. Peers Bank of America and Citigroup are similarly positioned to benefit, though facing comparable headwinds.
S&P 500 Boom Is Sending Older Americans Into ‘Retirement Party,’ Economists Say ‘Strength of the Equity Market Is Partly to Blame’
Stock gains are encouraging Americans to retire, while economists warn a downturn could hurt workers.
Will AI Become BAC's Next Major Efficiency & Growth Lever?
Bank of America has transitioned its AI strategy from experimentation to deployment, implementing 130-140 AI use cases with $400M in investment generating approximately $800M in benefits. The bank expects 50 new use cases quarterly and plans to double its AI budget next year. Erica digital assistant has surpassed 3.2B client interactions, while AI tools are boosting employee productivity by 10-15%. Peers JPMorgan and Wells Fargo are similarly expanding AI adoption across operations for efficiency and customer engagement.
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.